Citrullination, the conversion of peptidyl-arginine into peptidyl-citrulline, is involved in the breakage of self-tolerance in anti-CCP-positive rheumatoid arthritis. This reaction is catalyzed by peptidyl arginine deiminases (PADs), of which PAD2 and PAD4 are thought to play key pathogenic roles. Small-molecule PAD inhibitors such as the pan-PAD inhibitor BB-Cl-amidine, the PAD2-specific inhibitor AFM-30a, and the PAD4-specific inhibitor GSK199 hold therapeutic potential and are useful tools in studies of citrullination. Using an ELISA based on the citrullination of fibrinogen, we found that AFM-30a inhibited the catalytic activity of PADs derived from live PMNs or lysed PBMCs and PMNs and of PADs in cell-free synovial fluid samples from RA patients, while GSK199 had minor effects. In combination, AFM-30a and GSK199 inhibited total intracellular citrullination and citrullination of histone H3 in PBMCs, as determined by Western blotting. They were essentially nontoxic to CD4+ T cells, CD8+ T cells, B cells, NK cells, and monocytes at concentrations ranging from 1 to 20 μM, while BB-Cl-amidine was cytotoxic at concentrations above 1 μM, as assessed by flow cytometric viability staining and by measurement of lactate dehydrogenase released from dying cells. In conclusion, AFM-30a is an efficient inhibitor of PAD2 derived from PBMCs, PMNs, or synovial fluid. AFM-30a and GSK199 can be used in combination for inhibition of PAD activity associated with PBMCs but without the cytotoxic effect of BB-Cl-amidine. This suggests that AFM-30a and GSK199 may have fewer off-target effects than BB-Cl-amidine and therefore hold greater therapeutic potential.

Department of Biochemistry and Pharmacology University of Massachusetts Medical School Worcester MA United States

Department of Proteomics Novo Nordisk Foundation Center for Protein Research Faculty of Health and Medical Sciences University of Copenhagen Copenhagen Denmark

Institute for Inflammation Research Center for Rheumatology and Spine Diseases Rigshospitalet Copenhagen University Hospital Copenhagen Denmark

Institute of Rheumatology and Department of Rheumatology 1st Faculty of Medicine Charles University Prague Czechia

LEO Foundation Skin Immunology Research Center Department of Immunology and Microbiology University of Copenhagen Copenhagen Denmark

Section for Periodontology Department of Odontology Faculty of Health and Medical Sciences University of Copenhagen Copenhagen Denmark

Zobrazit více v PubMed

Vossenaar ER, Zendman AJW, Van Venrooij WJ, Pruijn GJM. PAD, A Growing Family of Citrullinating Enzymes: Genes, Features and Involvement in Disease. BioEssays (2003) 25(11):1106–18. doi: 10.1002/bies.10357 PubMed DOI

Arita K, Hashimoto H, Shimizu T, Nakashima K, Yamada M, Sato M. Structural Basis for Ca2+-Induced Activation of Human PAD4. Nat Struct Mol Biol (2004) 11(8):777–83. doi: 10.1038/nsmb799 PubMed DOI

Zheng L, Nagar M, Maurais AJ, Slade DJ, Parelkar SS, Coonrod SA, et al. . Calcium Regulates the Nuclear Localization of Protein Arginine Deiminase 2. Biochemistry (2019) 58(27):3042–56. doi: 10.1021/acs.biochem.9b00225 PubMed DOI PMC

Moscarello MA, Wood DD, Ackerley C, Boulias C. Myelin in Multiple Sclerosis Is Developmentally Immature. J Clin Invest (1994) 94(1):146–54. doi: 10.1172/JCI117300 PubMed DOI PMC

Rogers G, Winter B, McLaughlan C, Powell B, Nesci T. Peptidylarginine Deiminase of the Hair Follicle: Characterization, Localization, and Function in Keratinizing Tissues. J Invest Dermatol (1997) 108(5):700–7. doi: 10.1111/1523-1747.ep12292083 PubMed DOI

Christophorou MA, Castelo-Branco G, Halley-Stott RP, Oliveira CS, Loos R, Radzisheuskaya A, et al. . Citrullination Regulates Pluripotency and Histone H1 Binding to Chromatin. Nature (2014) 507(7490):104–8. doi: 10.1038/nature12942 PubMed DOI PMC

Schellekens GA, De Jong BAW, Van Den Hoogen FHJ, Van De Putte LBA, Van Venrooij WJ. Citrulline Is an Essential Constituent of Antigenic Determinants Recognized by Rheumatoid Arthritis-Specific Autoantibodies. J Clin Invest (1998) 101(1):273–81. doi: 10.1172/JCI1316 PubMed DOI PMC

Schellekens GA, Visser H, De Jong BAW, Van Den Hoogen FHJ, Hazes JMW, Breedveld FC, et al. . The Diagnostic Properties of Rheumatoid Arthritis Antibodies Recognizing a Cyclic Citrullinated Peptide. Arthritis Rheum (2000) 43(1):155–63. doi: 10.1002/1529-0131(200001)43:1<155::AID-ANR20>3.0.CO;2-3 PubMed DOI

Musse AA, Zhen L, Ackerley CA, Bienzle D, Lei H, Poma R, et al. . Peptidylarginine Deiminase 2 (PAD2) Overexpression in Transgenic Mice Leads to Myelin Loss in the Central Nervous System. DMM Dis Model Mech (2008) 1(4–5):229–40. doi: 10.1242/dmm.000729 PubMed DOI PMC

Harauz G, Musse AA. A Tale of Two Citrullines - Structural and Functional Aspects of Myelin Basic Protein Deimination in Health and Disease. Neurochem Res (2007) 32(2):137–58. doi: 10.1007/s11064-006-9108-9 PubMed DOI

Horibata S, Rogers KE, Sadegh D, Anguish LJ, McElwee JL, Shah P, et al. . Role of Peptidylarginine Deiminase 2 (PAD2) in Mammary Carcinoma Cell Migration. BMC Cancer (2017) 17(1):1–14. doi: 10.1186/s12885-017-3354-x PubMed DOI PMC

Chang X, Han J, Pang L, Zhao Y, Yang Y, Shen Z. Increased PADI4 Expression in Blood and Tissues of Patients With Malignant Tumors. BMC Cancer (2009) 9:1–11. doi: 10.1186/1471-2407-9-40 PubMed DOI PMC

Yuzhalin AE, Bording-Weeks AN, Tognoli ML, Jones K, Markelc B, Konietzny R, et al. . Colorectal Cancer Liver Metastatic Growth Depends on PAD4-Driven Citrullination of the Extracellular Matrix. Nat Commun (2018) 9(1):4783. doi: 10.1038/s41467-018-07306-7 PubMed DOI PMC

Vossenaar ER, Radstake TRD, van der Heijden A, Van Mansum MAM, Dieteren C, De Rooij DJ, et al. . Expression and Activity of Citrullinating Peptidylarginine Deiminase Enzymes in Monocytes and Macrophages. Ann Rheum Dis (2004) 63(4):373–81. doi: 10.1136/ard.2003.012211 PubMed DOI PMC

Foulquier C, Sebbag M, Clavel C, Chapuy-Regaud S, Al Badine R, Méchin MC, et al. . Peptidyl Arginine Deiminase Type 2 (PAD-2) and PAD-4 But Not PAD-1, PAD-3, and PAD-6 Are Expressed in Rheumatoid Arthritis Synovium in Close Association With Tissue Inflammation. Arthritis Rheum (2007) 56(11):3541–53. doi: 10.1002/art.22983 PubMed DOI

Spengler J, Lugonja B, Jimmy Ytterberg A, Zubarev RA, Creese AJ, Pearson MJ, et al. . Release of Active Peptidyl Arginine Deiminases by Neutrophils can Explain Production of Extracellular Citrullinated Autoantigens in Rheumatoid Arthritis Synovial Fluid. Arthritis Rheumatol (2015) 67(12):3135–45. doi: 10.1002/art.39313 PubMed DOI PMC

Engström M, Eriksson K, Lee L, Hermansson M, Johansson A, Nicholas AP, et al. . Increased Citrullination and Expression of Peptidylarginine Deiminases Independently of P. Gingivalis and A. Actinomycetemcomitans in Gingival Tissue of Patients With Periodontitis. J Transl Med (2018) 16(1):1–14. doi: 10.1186/s12967-018-1588-2 PubMed DOI PMC

Harre U, Georgess D, Bang H, Bozec A, Axmann R, Ossipova E, et al. . Induction of Osteoclastogenesis and Bone Loss by Human Autoantibodies Against Citrullinated Vimentin. J Clin Invest (2012) 122(5):1791–802. doi: 10.1172/JCI60975 PubMed DOI PMC

Makrygiannakis D, af Klint E, Lundberg IE, Lofberg R, Ulfgren A-K, Klareskog L, et al. . Citrullination Is an Inflammation-Dependent Process. Ann Rheum Dis (2006) 65(9):1219–22. doi: 10.1136/ard.2005.049403 PubMed DOI PMC

Harvey GP, Fitzsimmons TR, Dhamarpatni AASSK, Marchant C, Haynes DR, Bartold PM. Expression of Peptidylarginine Deiminase-2 and -4, Citrullinated Proteins and Anti-Citrullinated Protein Antibodies in Human Gingiva. J Periodontal Res (2013) 48(2):252–61. doi: 10.1111/jre.12002 PubMed DOI

Damgaard D, Senolt L, Nielsen CH. Increased Levels of Peptidylarginine Deiminase 2 in Synovial Fluid From Anti-CCP-Positive Rheumatoid Arthritis Patients: Association With Disease Activity and Inflammatory Markers. Rheumatol (United Kingdom) (2016) 55(5):918–27. doi: 10.1093/rheumatology/kev440 PubMed DOI PMC

Makrygiannakis D, Hermansson M, Ulfgren A-K, Nicholas AP, Zendman AJW, Eklund A, et al. . Smoking Increases Peptidylarginine Deiminase 2 Enzyme Expression in Human Lungs and Increases Citrullination in BAL Cells. Ann Rheum Dis (2008) 67(10):1488–92. doi: 10.1136/ard.2007.075192 PubMed DOI

Damgaard D, Nielsen MFB, Gaunsbaek MQ, Nielsen CH. Smoking Is Associated With Increased Levels of Extra- Cellular Peptidylarginine Deiminase 2 (PAD2) in the Lungs. Clin Exp Rheumatol (2015) 33:405–8. PubMed

Bawadekar M, Shim D, Johnson CJ, Warner TF, Rebernick R, Damgaard D, et al. . Peptidylarginine Deiminase 2 Is Required for Tumor Necrosis Factor Alpha-Induced Citrullination and Arthritis, But Not Neutrophil Extracellular Trap Formation. J Autoimmun (2017) 80(2017):39–47. doi: 10.1016/j.jaut.2017.01.006 PubMed DOI PMC

Blachère NE, Parveen S, Frank MO, Dill BD, Molina H, Orange DE. High-Titer Rheumatoid Arthritis Antibodies Preferentially Bind Fibrinogen Citrullinated by Peptidylarginine Deiminase 4. Arthritis Rheumatol (2017) 69(5):986–95. doi: 10.1002/art.40035 PubMed DOI PMC

Damgaard D, Bawadekar M, Senolt L, Stensballe A, Shelef MA, Nielsen CH. Relative Efficiencies of Peptidylarginine Deiminase 2 and 4 in Generating Target Sites for Anti-Citrullinated Protein Antibodies in Fibrinogen, Alpha-Enolase and Histone H3. PloS One (2018) 13(8):1–14. doi: 10.1371/journal.pone.0203214 PubMed DOI PMC

Poulsen TBG, Damgaard D, Jørgensen MM, Senolt L, Blackburn JM, Nielsen CH, et al. . Identification of Novel Native Autoantigens in Rheumatoid Arthritis. Biomedicines (2020) 8(6):1–13. doi: 10.3390/biomedicines8060141 PubMed DOI PMC

Mondal S, Thompson PR. Protein Arginine Deiminases (PADs): Biochemistry and Chemical Biology of Protein Citrullination. Acc Chem Res (2019) 52(3):818–32. doi: 10.1021/acs.accounts.9b00024 PubMed DOI PMC

Ledet MM, Anderson R, Harman R, Muth A, Thompson PR, Coonrod SA, et al. . BB-Cl-Amidine as a Novel Therapeutic for Canine and Feline Mammary Cancer via Activation of the Endoplasmic Reticulum Stress Pathway. BMC Cancer (2018) 18(1):1–13. doi: 10.1186/s12885-018-4323-8 PubMed DOI PMC

Kawalkowska J, Quirke A-M, Ghari F, Davis S, Subramanian V, Thompson PR, et al. . Abrogation of Collagen-Induced Arthritis by a Peptidyl Arginine Deiminase Inhibitor Is Associated With Modulation of T Cell-Mediated Immune Responses. Sci Rep (2016) 6(February):26430. doi: 10.1038/srep26430 PubMed DOI PMC

Willis VC, Gizinski AM, Banda NK, Causey CP, Knuckley B, Cordova KN, et al. . N-α-Benzoyl-N5-(2-Chloro-1-Iminoethyl)-L-Ornithine Amide, a Protein Arginine Deiminase Inhibitor, Reduces the Severity of Murine Collagen-Induced Arthritis. J Immunol (2011) 186(7):4396–404. doi: 10.4049/jimmunol.1001620 PubMed DOI PMC

Chumanevich AA, Causey CP, Knuckley BA, Jones JE, Poudyal D, Chumanevich AP, et al. . Suppression of Colitis in Mice by Cl-Amidine: A Novel Peptidylarginine Deiminase Inhibitor. Am J Physiol - Gastrointest Liver Physiol (2011) 300(6):929–38. doi: 10.1152/ajpgi.00435.2010 PubMed DOI PMC

Knight JS, Subramanian V, O’Dell AA, Yalavarthi S, Zhao W, Smith CK, et al. . Peptidylarginine Deiminase Inhibition Disrupts NET Formation and Protects Against Kidney, Skin and Vascular Disease in Lupus-Prone MRL/lpr Mice. Ann Rheum Dis (2015) 74(12):2199–206. doi: 10.1136/annrheumdis-2014-205365 PubMed DOI PMC

Lewis HD, Liddle J, Coote JE, Atkinson SJ, Barker MD, Bax BD, et al. . Inhibition of PAD4 Activity Is Sufficient to Disrupt Mouse and Human NET Formation. Nat Chem Biol (2015) 11(3):189–91. doi: 10.1038/nchembio.1735 PubMed DOI PMC

Muth A, Subramanian V, Beaumont E, Nagar M, Kerry P, McEwan P, et al. . Development of a Selective Inhibitor of Protein Arginine Deiminase 2. J Med Chem (2017) 60(7):3198–211. doi: 10.1021/acs.jmedchem.7b00274 PubMed DOI PMC

Willis VC, Banda NK, Cordova KN, Chandra PE, Robinson WH, Cooper DC, et al. . Protein Arginine Deiminase 4 Inhibition Is Sufficient for the Amelioration of Collagen-Induced Arthritis. Clin Exp Immunol (2017) 188(2):263–74. doi: 10.1111/cei.12932 PubMed DOI PMC

Liu Y, Lightfoot YL, Seto N, Carmona-Rivera C, Moore E, Goel R, et al. . Peptidylarginine Deiminases 2 and 4 Modulate Innate and Adaptive Immune Responses in TLR-7-Dependent Lupus. JCI Insight (2018) 3(23):e124729. doi: 10.1172/jci.insight.124729 PubMed DOI PMC

Hutchinson D. Classification Criteria: The 1987 American Rheumatism Association Revised Criteria for the Classification of Rheumatoid Arthritis. CPD Rheumatol (1999) 1(1):13–4. doi: 10.1002/art.1780310302 DOI

Damgaard D, Bjorn ME, Steffensen MA, Pruijn GJM, Nielsen CH. Reduced Glutathione as a Physiological Co-Activator in the Activation of Peptidylarginine Deiminase. Arthritis Res Ther (2016) 18(1):102. doi: 10.1186/s13075-016-1000-7 PubMed DOI PMC

Zhou Y, Chen B, Mittereder N, Chaerkady R, Strain M, An L-L, et al. . Spontaneous Secretion of the Citrullination Enzyme PAD2 and Cell Surface Exposure of PAD4 by Neutrophils. Front Immunol (2017) 8:1–16. doi: 10.3389/fimmu.2017.01200 PubMed DOI PMC